Role of Helicobacter pylori in esophageal carcinogenesis:Friend or foe?  

作　　者：Cong Zhang Yong-Wen Ouyang Zhao-Tao Li 

机构地区：[1]Department of Gastroenterology,The First People’s Hospital of Foshan,Foshan 528000,Guangdong Province,China

出　　处：《World Journal of Gastroenterology》2024年第44期4759-4762,共4页世界胃肠病学杂志（英文）

基　　金：Supported by the Guangdong Basic and Applied Basic Research Foundation,No.2023A1515140118.

摘　　要：In this letter,we comment on the article by López-Gómez et al,which explores the prevalence of Helicobacter pylori(H.pylori)infection among patients with esophageal carcinoma(EC)in a cohort of Spain population.The relationship between H.pylori infection and EC is very complex.Previous research results are often contradictory due to the influence of dietary habits,age,region,and other factors.López-Gómez et al reported a very low prevalence of previous H.pylori infection in their cohort of patients with EC,and most of them had previously received or concomitantly received proton pump inhibitors treatment.These results are similar to previous results,which suggest that H.pylori infection is related to the low incidence of EC.Therefore,this study may provide a direction for preventing EC and eradicating H.pylori in Spain.

关 键 词：Helicobacter pylori Esophageal carcinoma Esophageal squamous cell carcinoma Esophageal adenocarcinoma Proton pump inhibitors 

分 类 号：R735.1[医药卫生—肿瘤]